Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Nexviadyme, Avalglucosidase alfa, Glycogen Storage Disease Type II, Date of authorisation: 24/06/2022, Revision: 1, Status: Authorised
TO: